| Outcomes of periurethral submucosal injection therapy | Arman ÖZDEMİR,Çetin ÇAM,Ateş KARATEKE,Turhan ARAN,Esra ARAN | 1–3 |
| Total antioxidant status in hyperprolactinemia: effects of bromocriptine therapy | Fatma Ferda VERİT,Özcan EREL | 5–9 |
| The comparasion of Menopause Rating scale (MRS), Kupperman Index (KI) and Nottingham Health Profile (NHP) by means of reliability measures and responsiveness ındexes among menopausal women | Nural BEKİROĞLU,Ayşe GÜRBÜZ,Rana KONYALIOĞLU,SELÇUK AYAS,Akif ALKAN,Sadiye EREN | 11–15 |
| The corelation between anti Mullerian Hormone levels and size of endometrioma | Namık Kemal DURU,SEYİT TEMEL CEYHAN,İbrahim ALANBAY,Uğur KESKİN,Murat MUHCU,İskender BAŞER | 17–19 |
| Expression of Glut-1 in benign, borderline and malignnat tumors of the ovary, its relationship with prognostic parameters | Müberra Seğmen YILMAZ,Dilek YAVUZER,Nimet KARADAY,Aylin Ege GÜL,Gözde KIR | 21–25 |
| In vitro fertilization and Anti-Mullerian hormone | Namık Kemal DURU,SEYİT TEMEL CEYHAN,İbrahim ALANBAY,Murat MUHCU,Uğur KESKİN,İskender BAŞER | 27–31 |
| Large-cell variant of small cell carcinoma of the ovary in pregnancy: a case report | SELÇUK AYAS,Ayşe GÜRBÜZ,Akif ALKAN,Ateş KARATEKE,Handan ÇETİNNER | 33–35 |
| Spindle cell malignant tumor / sarcomatoid carcinoma of the breast: case report | Müberra Seğmen YILMAZ,Gözde KIR,Filiz ALPTEKİN,Kenan MURAT,Metin YÜCEL | 37–39 |
| Uncommon hereditary dermatological diseases in newbornhood: presentation of the three cases presentation of the three cases | Aysun KARADAĞ,Gülcihan KERİMOĞLU,Hüseyin DAĞ,Sayat GÜLBAYZAR,Sami HATİPOĞLU | 41–44 |